Neurocrine Bioscience buy Citigroup Inc.
Start price
29.10.25
/
50%
€117.75
Target price
29.10.26
€174.28
Performance (%)
-11.93%
Price
12.02.26
€103.70
Summary
This prediction is currently active. The prediction for Neurocrine Bioscience disappoints with a performance of -11.93%. This prediction currently runs until 29.10.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -11.405% | -11.405% |
| iShares Core DAX® | 1.927% | -2.112% |
| iShares Nasdaq 100 | -0.184% | -5.899% |
| iShares Nikkei 225® | 7.076% | 6.457% |
| iShares S&P 500 | -0.201% | -3.667% |
Comments by Citigroup_Inc_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its price target raised by analysts at Citigroup Inc. from $175.00 to $203.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€103.35
12.02.26
12.02.26
€171.73
12.02.27
12.02.27
0.34%
12.02.26
12.02.26
